HOWL
Price
$0.92
Change
-$0.17 (-15.60%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
52.67M
126 days until earnings call
Intraday BUY SELL Signals
OCUL
Price
$11.18
Change
-$0.31 (-2.70%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.45B
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HOWL vs OCUL

Header iconHOWL vs OCUL Comparison
Open Charts HOWL vs OCULBanner chart's image
Werewolf Therapeutics
Price$0.92
Change-$0.17 (-15.60%)
Volume$400
Capitalization52.67M
Ocular Therapeutix
Price$11.18
Change-$0.31 (-2.70%)
Volume$47.12K
Capitalization2.45B
HOWL vs OCUL Comparison Chart in %
HOWL
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HOWL vs. OCUL commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (HOWL: $1.09 vs. OCUL: $11.49)
Brand notoriety: HOWL and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 47% vs. OCUL: 65%
Market capitalization -- HOWL: $52.67M vs. OCUL: $2.45B
HOWL [@Biotechnology] is valued at $52.67M. OCUL’s [@Biotechnology] market capitalization is $2.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, both HOWL and OCUL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • HOWL’s TA Score: 4 bullish, 6 bearish.
  • OCUL’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, OCUL is a better buy in the short-term than HOWL.

Price Growth

HOWL (@Biotechnology) experienced а -10.66% price change this week, while OCUL (@Biotechnology) price change was +6.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

HOWL is expected to report earnings on Mar 19, 2026.

OCUL is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.45B) has a higher market cap than HOWL($52.7M). OCUL YTD gains are higher at: 34.543 vs. HOWL (-26.351). HOWL has higher annual earnings (EBITDA): -66.34M vs. OCUL (-200.5M). OCUL has more cash in the bank: 391M vs. HOWL (77.6M). HOWL has less debt than OCUL: HOWL (37.1M) vs OCUL (76.9M). OCUL has higher revenues than HOWL: OCUL (56.7M) vs HOWL (0).
HOWLOCULHOWL / OCUL
Capitalization52.7M2.45B2%
EBITDA-66.34M-200.5M33%
Gain YTD-26.35134.543-76%
P/E RatioN/AN/A-
Revenue056.7M-
Total Cash77.6M391M20%
Total Debt37.1M76.9M48%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HOWLOCUL
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 7 days ago
86%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend about 1 month ago
82%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMUBX26.390.22
+0.84%
MFS Utilities B
IPFPX57.380.13
+0.23%
Poplar Forest Partners Institutional
MVTIX11.35N/A
N/A
Transamerica Mid Cap Value Opps I
RMOCX18.25-0.02
-0.11%
Victory RS Mid Cap Growth C
LGRRX30.19-0.16
-0.53%
Loomis Sayles Growth A

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with ATNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-3.54%
ATNM - HOWL
42%
Loosely correlated
-0.76%
CLDX - HOWL
41%
Loosely correlated
-0.49%
OCUL - HOWL
40%
Loosely correlated
+2.41%
CRBU - HOWL
39%
Loosely correlated
+0.89%
RXRX - HOWL
39%
Loosely correlated
-1.27%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+2.41%
IDYA - OCUL
57%
Loosely correlated
-0.19%
EYPT - OCUL
55%
Loosely correlated
+2.96%
DNLI - OCUL
55%
Loosely correlated
-0.34%
ERAS - OCUL
54%
Loosely correlated
+12.29%
RVMD - OCUL
53%
Loosely correlated
+2.73%
More